Chinese budget retailer eyes HK for US$1b IPO

Also, Tasly Biopharmaceuticals, a biopharma unit of Shanghai-listed Tasly Pharmaceutical Group, plans to raise about US$500 million from a Hong Kong IPO, according to Reuters IFR. Meanwhile, Ernst & ... ( read original story ...)

StanChart scraps banking fees

Standard Chartered Bank Hong Kong announced it ill scrap its premium banking and easy banking's below amount fees from August 1.Earlier, The Hongkong and Shanghai Banking Corporation and Bank of China ... ( read original story ...)

Yam calls for solidarity in financial sector

issued a rare press release to call for the Hong Kong financial community to stick together, continue the commitment to work, be vigilant and prudent to face the complex financial situation. Yam said ... ( read original story ...)